A study from the Polleux lab shows an extra copy of a brain-development gene allowed neurons to migrate farther and develop more connections as human evolution progressed. The findings may also offer a clue to autism and schizophrenia.
If the results from the Mason lab are confirmed by ongoing larger trials, the drug gabapentin could become the first FDA-approved pharmaceutical treatment for cannabis dependence.
The results from the Scripps Research-UC San Diego collaboration suggest researchers implement careful quality control.
Assistant Professor Srini Subramaniam investigates the signaling networks involved in neurodegenerative diseases.